Immunosuppression in IgA nephropathy: how certain are we?
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 26759037.
- Also identified by DOI 10.1016/j.kint.2015.11.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The optimal role of immunosuppressive therapy in the treatment of IgA nephropathy is controversial. Results of a recently completed randomized controlled trial provide strong support for comprehensive supportive care rather than immunosuppressive therapy in patients at high risk for progression.
Medical subject headings
- Glomerulonephritis, IGA
- Immunosuppressive Agents